Calcium Gluconate Injection Fresenius
PDF Leaflet Revision Date: 07 February 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Intravenous calcium supplement.
Dosage (summary)
Adults: 1-2 g IV; Children: varies by age.
Special Populations
- Renal impairment
- Children under 18
Pregnancy & Breastfeeding
Safety not established in pregnancy or breastfeeding.
Key Drug Interactions
- Digoxin
- Adrenaline
- Thiazide diuretics
Contraindications
- Hypersensitivity
- Severe renal failure
- Hypercalcaemia
- Hypercalciuria
Common side effects
- Bradycardia
- Hypotension
- Nausea
- Vomiting
Counselling Points
- Monitor for signs of hypercalcaemia
- Administer slowly
- Avoid mixing with incompatible drugs
Serious warnings
- Risk of cardiac dysrhythmias
- Irritation at injection site
- Risk of precipitation with ceftriaxone
Important Disclaimer
The Calcium Gluconate Injection Fresenius professional information leaflet below is the property of Fresenius Kabi Manufacturing Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
